Investing.com - StemRIM reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
StemRIM announced earnings per share of ¥-7.54 on revenue of ¥0.00. Analysts polled by Investing.com anticipated EPS of ¥-10 on revenue of ¥0.00.
StemRIM shares are up 27.81% from the beginning of the year and are trading at ¥1,126.0 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
StemRIM follows other major Healthcare sector earnings this month
StemRIM's report follows an earnings matched by Asahi Intecc on Friday, August 12, 2022, who reported EPS of ¥11.53 on revenue of ¥21.06B, compared to forecasts EPS of ¥11.53 on revenue of ¥21.06B.
JEOL Ltd had beat expectations on Friday, August 12, 2022 with third quarter EPS of ¥63.03 on revenue of ¥28.86B, compared to forecast for EPS of ¥41.93 on revenue of ¥28.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar